On Monday, TriSalus Life Sciences Inc (NASDAQ: TLSI) was 4.93% up from the session before settling in for the closing price of $5.07. A 52-week range for TLSI has been $3.50 – $6.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -175.42%. When this article was written, the company’s average yearly earnings per share was at 37.75%. With a float of $15.89 million, this company’s outstanding shares have now reached $32.27 million.
Let’s determine the extent of company efficiency that accounts for 110 employees. In terms of profitability, gross margin is 85.6%, operating margin of -99.01%, and the pretax margin is -84.65%.
TriSalus Life Sciences Inc (TLSI) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward TriSalus Life Sciences Inc stocks. The insider ownership of TriSalus Life Sciences Inc is 58.16%, while institutional ownership is 8.08%. The most recent insider transaction that took place on May 19 ’25, was worth 24,678. In this transaction Chief of Research of this company sold 4,764 shares at a rate of $5.18, taking the stock ownership to the 119,415 shares. Before that another transaction happened on May 19 ’25, when Company’s Chief of Clinical Operations sold 4,764 for $5.18, making the entire transaction worth $24,678. This insider now owns 52,764 shares in total.
TriSalus Life Sciences Inc (TLSI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 37.75% per share during the next fiscal year.
TriSalus Life Sciences Inc (NASDAQ: TLSI) Trading Performance Indicators
You can see what TriSalus Life Sciences Inc (TLSI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.12, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.17 in one year’s time.
Technical Analysis of TriSalus Life Sciences Inc (TLSI)
Looking closely at TriSalus Life Sciences Inc (NASDAQ: TLSI), its last 5-days average volume was 0.41 million, which is a jump from its year-to-date volume of 60600.0. As of the previous 9 days, the stock’s Stochastic %D was 30.77%.
During the past 100 days, TriSalus Life Sciences Inc’s (TLSI) raw stochastic average was set at 56.25%, which indicates a significant increase from 49.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.36% in the past 14 days, which was higher than the 53.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.35, while its 200-day Moving Average is $4.93. However, in the short run, TriSalus Life Sciences Inc’s stock first resistance to watch stands at $5.53. Second resistance stands at $5.75. The third major resistance level sits at $5.99. If the price goes on to break the first support level at $5.07, it is likely to go to the next support level at $4.83. Now, if the price goes above the second support level, the third support stands at $4.61.
TriSalus Life Sciences Inc (NASDAQ: TLSI) Key Stats
There are 37,839K outstanding shares of the company, which has a market capitalization of 202.03 million. As of now, sales total 29,430 K while income totals -30,050 K. Its latest quarter income was 9,170 K while its last quarter net income were -10,380 K.
